March 27th Options Now Available For Broadcom (AVGO)

Broadcom (AVGO) options setups are highlighted: a $310 put is bid at $23.60, which nets a $286.40 effective share cost if sold-to-open (current stock $316.73), is ~2% out-of-the-money and has a 57% probability of expiring worthless, implying a 7.61% return (55.62% annualized) if it does. On the call side, a $320 call is bid at $23.85 for use as a covered call (≈1% OTM), offering an 8.56% total return if called at the March 27 expiration and a 48% chance to expire worthless, equating to a 7.53% premium boost (55.02% annualized); implied vols are ~60% (put) and 59% (call) versus a 12‑month realized vol of ~50%.

Analysis

Market structure: Short-dated option sellers and yield-seeking income strategies are immediate beneficiaries—selling the AVGO Mar27 310 put yields an effective entry at $286.40 (≈9.5% below spot) with a 57% modeled chance to keep premium; covered-call sellers at 320 lock in ~8.6% to expiry. Long-only holders and momentum traders lose upside capture if shares gap above 320 and get called; market makers and IV sellers gain if realized vol reverts toward the 50% trailing figure from the 59–60% IV.

Risk assessment: Tail risks include semiconductor demand shock, adverse Broadcom M&A/regulatory surprises, or a market-wide vol spike that pushes IV >>70% and makes short-premium strategies losses exceed collected premium. Immediate risks (days) are gamma/assignment near Mar27; short-term (weeks-months) is IV mean-reversion around earnings/M&A windows; long-term (quarters) is secular semiconductor cyclicality and software-integration execution that could compress multiples by >10–20%.

Trade implications: Tactical: implement cash-secured 310 puts (size 1–3% portfolio) only if willing to own at $286.40 and cap max notional per name; alternative buy-write at 320 on existing shares to harvest ~7.5% to Mar27. Volatility approach: favor selling premium rather than buying — but use defined-risk iron-condors (e.g., 300/310P and 320/330C wings) or hedge with a 1–2% long-delta position if IV>60% and time to earnings <30 days.

Contrarian angles: Consensus prizes yield from selling AVGO premium but underestimates event risk — IV could rerate higher around an acquisition/earnings/capital-allocation update, rendering short premium punitive. Historically, selling premium into elevated IV (e.g., 2022 drawdowns) was fatally underprotected; if you expect AVGO-specific positive corporate actions, covered-call is underpriced and likely to be assigned — treat assignment as pre-approved buy/sell, not a failure.

Key Decisions for Investors

• Sell-to-open cash-secured AVGO Mar27 310 puts for premium ≈$23.60 only if you are willing to own AVGO at $286.40; limit exposure to 1–3% of portfolio and reserve cash of $28,640 per contract (100 shares) — close or roll if AVGO < $300 or IV > 70%.
• Initiate buy-write: buy AVGO up to 2% portfolio and sell Mar27 320 calls (collect ≈$23.85) to lock ~8.6% return to expiry; set a rule to roll or buy back calls if AVGO rallies >5% before expiry to avoid involuntary assignment into a >10% gap.
• If you prefer defined-risk volatility selling, construct iron-condors around Mar27 (sell 310P/320C, buy 300P/330C wings) sized so max loss ≤2% portfolio; priority to execute if IV remains ≥59% and realized vol stays ~50% over next 30 days.
• Pair trade: go long AVGO (1% portfolio) and short SOXX (0.5x notional) to isolate Broadcom-specific fundamentals vs broad semiconductor cyclicality; reassess after quarterly results or any M&A rumors within 60 days.
• Hard trigger rules: liquidate or hedge short-premium positions if AVGO gaps ±8% in 5 trading days, IV spikes >70%, or Broadcom announces M&A/earnings within 30–60 days — these conditions historically convert income trades into large losses.